treatment
Outcomes of Adding a Fourth Chemotherapy Course in AML
A Caregiver's Story: MDS Diagnosis Changes their Lives
I know my fiancé well. Even though he seemed to be healthy and his job kept him active, I knew it had been a long time since he had a medical physical, so I pushed him into an appointment.
Without symptoms, the doctor suggested routine blood work as a part of the physical. We were surprised that all his counts were low. The doctor decided to check again in a month, so I made sure that his diet was healthier and that he took vitamins, hoping that would correct any problem.
Severe Aplastic Anemia and PNH Diagnoses Came out of Nowhere - Marianna's Story
As a typical community college student, Mariana was busy. Classes, studying, day trips, all were part of her life. Yet during one shower, she dropped to the floor, suddenly dizzy. A few weeks later she would be out of breath, with unusual bruises on her skin.
Ivosidenib and Azacitidine Combination Demonstrates Durable Activity in Newly Diagnosed AML
Pegcetacoplan Bests Eculizumab for PNH Patients
Results from the phase III PEGASUS trial suggest that the targeted C3 inhibitor pegcetacoplan improved hemoglobin levels better than eculizumab in patients with
Overcoming Clinical Challenges Associated With TP53-Mutant MDS, AML
Guadecitabine Maintenance Therapy Shows Promise in High Risk MDS/AML Patients
Oral Azacitidine Improves, Sustains Health-Related QoL in AML
Treatment with the oral agent showed sustained health-related quality of life compared with placebo in patients with